Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 103.5 | 50 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 104.0 | 61 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 116.0 | 62 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 109.0 | 57 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 49.0 | 51 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 49.0 | 65 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 51.0 | 52 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 43.5 | 46 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 46.0 | 67 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 47.0 | 66 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 40.5 | 44 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 54.0 | 71 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 64.0 | 56 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 99.0 | 60 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 81.0 | 53 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 96.0 | 53 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 78.0 | 60 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 84.5 | 54 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 89.5 | 60 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | FGF Basic | 98.0 | 46 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | FGF Basic | 44.0 | 75 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | FGF Basic | 45.5 | 54 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | FGF Basic | 38.0 | 64 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | FGF Basic | 41.5 | 54 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | FGF Basic | 30.0 | 65 |